Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Fumarate Copolymer-Chitosan Cross-Linked Scaffold Directed to Osteochondrogenic Tissue Engineering.

Lastra ML, Molinuevo MS, Cortizo AM, Cortizo MS.

Macromol Biosci. 2016 Nov 28. doi: 10.1002/mabi.201600219. [Epub ahead of print]

PMID:
27892651
2.

Novel Vanadium-Loaded Ordered Collagen Scaffold Promotes Osteochondral Differentiation of Bone Marrow Progenitor Cells.

Cortizo AM, Ruderman G, Mazzini FN, Molinuevo MS, Mogilner IG.

Int J Biomater. 2016;2016:1486350. doi: 10.1155/2016/1486350. Epub 2016 May 11.

3.

Tautomerizable β-ketonitrile copolymers for bone tissue engineering: Studies of biocompatibility and cytotoxicity.

Lastra ML, Molinuevo MS, Giussi JM, Allegretti PE, Blaszczyk-Lezak I, Mijangos C, Cortizo MS.

Mater Sci Eng C Mater Biol Appl. 2015 Jun;51:256-62. doi: 10.1016/j.msec.2015.03.008. Epub 2015 Mar 11.

PMID:
25842133
4.

Strontium ranelate stimulates the activity of bone-specific alkaline phosphatase: interaction with Zn(2+) and Mg (2+).

Fernández JM, Molinuevo MS, McCarthy AD, Cortizo AM.

Biometals. 2014 Jun;27(3):601-7. doi: 10.1007/s10534-014-9733-8. Epub 2014 Apr 16.

PMID:
24737106
5.

Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells.

Sbaraglini ML, Molinuevo MS, Sedlinsky C, Schurman L, McCarthy AD.

Eur J Pharmacol. 2014 Mar 15;727:8-14. doi: 10.1016/j.ejphar.2014.01.028. Epub 2014 Jan 28.

PMID:
24485890
6.

Effects of a metabolic syndrome induced by a fructose-rich diet on bone metabolism in rats.

Felice JI, Gangoiti MV, Molinuevo MS, McCarthy AD, Cortizo AM.

Metabolism. 2014 Feb;63(2):296-305. doi: 10.1016/j.metabol.2013.11.002. Epub 2013 Nov 7.

PMID:
24355623
7.

Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin.

Tolosa MJ, Chuguransky SR, Sedlinsky C, Schurman L, McCarthy AD, Molinuevo MS, Cortizo AM.

Diabetes Res Clin Pract. 2013 Aug;101(2):177-86. doi: 10.1016/j.diabres.2013.05.016. Epub 2013 Jun 24.

PMID:
23806481
8.

Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.

Fernández JM, Molinuevo MS, Sedlinsky C, Schurman L, Cortizo AM, McCarthy AD.

Eur J Pharmacol. 2013 Apr 15;706(1-3):41-7. doi: 10.1016/j.ejphar.2013.02.042. Epub 2013 Mar 13.

PMID:
23499695
9.

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.

Sedlinsky C, Molinuevo MS, Cortizo AM, Tolosa MJ, Felice JI, Sbaraglini ML, Schurman L, McCarthy AD.

Eur J Pharmacol. 2011 Oct 15;668(3):477-85. doi: 10.1016/j.ejphar.2011.07.033. Epub 2011 Aug 5.

PMID:
21839072
10.

Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering.

Fernandez JM, Molinuevo MS, Cortizo MS, Cortizo AM.

J Tissue Eng Regen Med. 2011 Jun;5(6):e126-35. doi: 10.1002/term.394. Epub 2011 Feb 10.

PMID:
21312338
11.

Characterization of poly(epsilon-caprolactone)/polyfumarate blends as scaffolds for bone tissue engineering.

Fernandez JM, Molinuevo MS, Cortizo AM, McCarthy AD, Cortizo MS.

J Biomater Sci Polym Ed. 2010;21(10):1297-312. doi: 10.1163/092050609X12517190417632. Epub 2010 Jun 8.

PMID:
20534186
12.

Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.

Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C.

J Bone Miner Res. 2010 Feb;25(2):211-21. doi: 10.1359/jbmr.090732.

13.

Biocompatibility and biodegradation of polyester and polyfumarate based-scaffolds for bone tissue engineering.

Cortizo MS, Molinuevo MS, Cortizo AM.

J Tissue Eng Regen Med. 2008 Jan;2(1):33-42. doi: 10.1002/term.62.

PMID:
18273918
14.

Vanadium(IV) complexes inhibit adhesion, migration and colony formation of UMR106 osteosarcoma cells.

Molinuevo MS, Cortizo AM, Etcheverry SB.

Cancer Chemother Pharmacol. 2008 Apr;61(5):767-73. Epub 2007 Jun 19.

PMID:
17576559
15.

Alendronate induces anti-migratory effects and inhibition of neutral phosphatases in UMR106 osteosarcoma cells.

Molinuevo MS, Bruzzone L, Cortizo AM.

Eur J Pharmacol. 2007 May 7;562(1-2):28-33. Epub 2007 Feb 8.

PMID:
17341419
16.

Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action.

Cortizo AM, Molinuevo MS, Barrio DA, Bruzzone L.

Int J Biochem Cell Biol. 2006;38(7):1171-80. Epub 2006 Jan 9.

PMID:
16455285
17.

Macrophage activation by a vanadyl-aspirin complex is dependent on L-type calcium channel and the generation of nitric oxide.

Molinuevo MS, Etcheverry SB, Cortizo AM.

Toxicology. 2005 Jun 1;210(2-3):205-12.

PMID:
15840434
18.

Antitumoral properties of two new vanadyl(IV) complexes in osteoblasts in culture: role of apoptosis and oxidative stress.

Molinuevo MS, Barrio DA, Cortizo AM, Etcheverry SB.

Cancer Chemother Pharmacol. 2004 Feb;53(2):163-72. Epub 2003 Oct 9.

PMID:
14551736
19.

A simple method to assess the oxidative susceptibility of low density lipoproteins.

Scoccia AE, Molinuevo MS, McCarthy AD, Cortizo AM.

BMC Clin Pathol. 2001;1(1):1.

Supplemental Content

Loading ...
Support Center